Anti-inflammatory role of fenofibrate in treating diseases
DOI:
https://doi.org/10.17305/bb.2022.8534Keywords:
Fenofibrate, inflammation, mechanism, PPAR-α, diseases, therapyAbstract
Inflammation contributes to the pathogenesis of several diseases. Fenofibrate, known as a peroxisome proliferator-activated receptor - α (PPAR-α) agonist, is a classic drug for treating hyperlipidemia. In addition to its lipid-lowering effect, fenofibrate has also been reported to exert anti-inflammatory effects with complicated underlying mechanisms of action. In general, the anti-inflammatory effect of fenofibrate is secondary to its lipid-lowering effect, especially for the inflammation caused by hyperlipidemia in the circulatory system. Some anti-inflammatory actions may also come from its regulatory effects on intracellular lipid metabolism by activating PPAR-α. In addition, some roles in anti-inflammation might be mediated by its direct regulation of inflammatory signaling pathways. In order to understand anti-inflammatory activities and the underlying mechanisms of fenofibrate action in disease better, we herein reviewed and discussed the anti-inflammatory roles and its subserving mechanisms in various diseases of different organ systems. Thus, this review offers insights into the optimal use of fenofibrate in the clinical setting.
Citations
Downloads
![Anti-inflammatory role of fenofibrate in treating diseases](https://www.bjbms.org/ojs/public/journals/1/submission_8534_2668_coverImage_en_US.png)
Downloads
Additional Files
Published
License
Copyright (c) 2023 Lv Jin, Hu Hua, Yong Ji, Zhanjun Jia, Mingqi Peng, Songming Huang
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.